Triazolopyrimidyl - The Mechanisms of the Biological Activity of these Compounds - Non-Elaborate Posts - Post 7
Triazolopyrimidyls also display notable synergy with other bioactive molecules. In fungicide formulations, combinations with strobilurins or azoles often result in additive or synergistic effects, reducing the risk of resistance emergence. In pharmaceuticals, dual-acting triazolopyrimidyl derivatives are being engineered to simultaneously inhibit kinases and disrupt protein–protein interactions, reflecting the scaffold’s multifunctional capacity.
The pharmacodynamics of these compounds demonstrate sustained target engagement. Their metabolic stability, coupled with strong receptor binding, often leads to prolonged biological half-lives. While advantageous in reducing dosing frequency, prolonged activity necessitates careful toxicological evaluation to avoid off-target accumulation. The balance between efficacy and safety is therefore a central consideration in scaffold development.
Comments
Post a Comment